menu
    • menu

    Company profile for Calliditas Therapeutics AB

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Calliditas Therapeutics is a specialty pharmaceutical company focused on developing high value medical products for patients with significant unmet medical needs in niche indications, where the company can partially or completely participate in the commercialization. Calliditas is focused on the development and commercialization of its lead product candidate Nefecon, which has successfully completed a Phase 2b clinical trial, ...
    Calliditas Therapeutics is a specialty pharmaceutical company focused on developing high value medical products for patients with significant unmet medical needs in niche indications, where the company can partially or completely participate in the commercialization. Calliditas is focused on the development and commercialization of its lead product candidate Nefecon, which has successfully completed a Phase 2b clinical trial, as a potential new treatment for patients with inflammatory kidney disease (IgA nephropathy) who are at risk of progressing to renal failure.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Calliditas Therapeutics ABSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Kungsbron 1, C8 SE-111 22 Stockholm
    Telephone
    Telephone
    556659-9766
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.calliditas.se/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/calliditas-therapeutics-ab
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Calliditas Reports Data On Setanaxib In Alport Syndrome at ASN
    Calliditas Reports Data On Setanaxib In Alport Syndrome at ASN

    11 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calliditas-therapeutics-reports-safety-data-for-setanaxib-in-patients-with-alport-syndrome-at-the-american-society-of-nephrology-kidney-week-302610714.html

    PR NEWSWIRE
    11 Nov 2025
    Share Share
    Calliditas Therapeutics To Present At ASN Kidney Week
    Calliditas Therapeutics To Present At ASN Kidney Week

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calliditas-therapeutics-to-present-at-the-american-society-of-nephrology-kidney-week-302603270.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    Calliditas Presented at 62nd European Renal Association Congress
    Calliditas Presented at 62nd European Renal Association Congress

    09 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calliditas-therapeutics-presented-at-the-62nd-european-renal-association-congress-302476712.html

    PR NEWSWIRE
    09 Jun 2025
    Share Share
    Calliditas To Present Four Abstracts At ASN Kidney Week 2024
    Calliditas To Present Four Abstracts At ASN Kidney Week 2024

    16 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/16/2964011/0/en/Calliditas-Therapeutics-to-Present-Four-Abstracts-at-American-Society-of-Nephrology-ASN-Kidney-Week-2024.html

    GLOBENEWSWIRE
    16 Oct 2024
    Share Share
    Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm
    Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm

    16 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/delisting-of-calliditas-therapeutics-ab-publ-from-nasdaq-stockholm-302249090.html

    PR NEWSWIRE
    16 Sep 2024
    Share Share
    Calliditas Therapeutics Takes Corporate Actions Post Asahi Kasei News
    Calliditas Therapeutics Takes Corporate Actions Post Asahi Kasei News

    03 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calliditas-therapeutics-takes-certain-corporate-actions-following-announcement-by-asahi-kasei-302236575.html

    PR NEWSWIRE
    03 Sep 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search